AFNET – the Atrial Fibrillation NETwork

Physicians and scientists co-operate within the AFNET. A network is formed by hospitals and doctors’ offices – reaching from GPs to university hospitals.

Atrial Fibrillation – Information for Patients

Atrial Fibrillation is the most common arrhythmia of the heart – especially in elderly people. We inform you about the current treatment options.

Research – Clinical Trials on a European Level

Several million people in Europe live with atrial fibrillation. We investigate new treatment options. Within AFNET trials scientists co-operate on a European level.

Results – for a better treatment

New findings from AFNET trials flow into the clinical routine. AFNET experts develop recommendations for the therapy of atrial fibrillation.

1
2
3
4

Homepage

News

[02.03.2015 ] While NOACs are valid alternatives to vitamin K antagonist... [read more]
[19.05.2014 ] The treatment options for atrial fibrillation have been... [read more]
[20.12.2013 ] New classification comes after the first European... [read more]
[13.12.2013 ] The website of the German Competence Network on Atrial... [read more]
[14.11.2013 ] On 4th November 2013 the 1000th patient was enrolled in the... [read more]
[31.08.2013 ] In contrast, a CHA2DS2-VASc score of 0 identifies a... [read more]
[27.08.2013 ] The fourth AFNET/EHRA consensus conference was convened to... [read more]
[26.06.2013 ] The PREFER AF registry study, which provides a ‘snapshot’... [read more]
[25.06.2013 ] Using catheter ablation to create complete linear lesions... [read more]
[23.06.2013 ] The abstract study found that patients with paroxysmal AF,... [read more]

Pages